DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
44 hedge funds and large institutions have $150M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
22% more funds holding
Funds holding: 36 → 44 (+8)
7% less capital invested
Capital invested by funds: $162M → $150M (-$11.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$10.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$4.76M |
| 3 |
SC
Sculptor Capital
New York
|
+$4.6M |
| 4 |
LA
Linden Advisors
New York
|
+$3.68M |
| 5 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
+$3.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$28.1M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.81M |
| 3 |
HP
Hound Partners
New York
|
-$7.36M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.41M |
| 5 |
FIG
Fortress Investment Group
New York
|
-$2.17M |
DALS Hedge Fund Activity: Q1 2022 in Review
44 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q1 2022, worth a combined $150M — down 6.9% from $162M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new DALS positions and 7 closed out — a net gain of 8 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $10.8M. The largest seller was Wellington Management Group, exiting entirely with an estimated $28.1M sold.
- 44 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q1 2022, up from 36 in Q4 2021.
- Funds reported $150M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q1 2022, down 6.9% quarter-over-quarter.
- 15 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q1 2022 and 7 closed out, a net change of +8 holders.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q1 2022 was Saba Capital Management, an estimated $10.8M added.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q1 2022 was Wellington Management Group, an estimated $28.1M sold.
Based on aggregated 13F filings for Q1 2022.